Identifying co-targets to fight drug resistance based on a random walk model
- PMID: 22257493
- PMCID: PMC3296574
- DOI: 10.1186/1752-0509-6-5
Identifying co-targets to fight drug resistance based on a random walk model
Abstract
Background: Drug resistance has now posed more severe and emergent threats to human health and infectious disease treatment. However, wet-lab approaches alone to counter drug resistance have so far still achieved limited success due to less knowledge about the underlying mechanisms of drug resistance. Our approach apply a heuristic search algorithm in order to extract active network under drug treatment and use a random walk model to identify potential co-targets for effective antibacterial drugs.
Results: We use interactome network of Mycobacterium tuberculosis and gene expression data which are treated with two kinds of antibiotic, Isoniazid and Ethionamide as our test data. Our analysis shows that the active drug-treated networks are associated with the trigger of fatty acid metabolism and synthesis and nicotinamide adenine dinucleotide (NADH)-related processes and those results are consistent with the recent experimental findings. Efflux pumps processes appear to be the major mechanisms of resistance but SOS response is significantly up-regulation under Isoniazid treatment. We also successfully identify the potential co-targets with literature confirmed evidences which are related to the glycine-rich membrane, adenosine triphosphate energy and cell wall processes.
Conclusions: With gene expression and interactome data supported, our study points out possible pathways leading to the emergence of drug resistance under drug treatment. We develop a computational workflow for giving new insights to bacterial drug resistance which can be gained by a systematic and global analysis of the bacterial regulation network. Our study also discovers the potential co-targets with good properties in biological and graph theory aspects to overcome the problem of drug resistance.
Figures





Similar articles
-
targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis.BMC Syst Biol. 2008 Dec 19;2:109. doi: 10.1186/1752-0509-2-109. BMC Syst Biol. 2008. PMID: 19099550 Free PMC article.
-
Mycobacterium tuberculosis interactome analysis unravels potential pathways to drug resistance.BMC Microbiol. 2008 Dec 23;8:234. doi: 10.1186/1471-2180-8-234. BMC Microbiol. 2008. PMID: 19105810 Free PMC article.
-
Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance.Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01461-17. doi: 10.1128/AAC.01461-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28993337 Free PMC article.
-
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis: Genes, Mutations, and Causalities.Microbiol Spectr. 2014 Aug;2(4):MGM2-0014-2013. doi: 10.1128/microbiolspec.MGM2-0014-2013. Microbiol Spectr. 2014. PMID: 26104204 Free PMC article. Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis.Antimicrob Agents Chemother. 2013 Feb;57(2):751-7. doi: 10.1128/AAC.01482-12. Epub 2012 Nov 19. Antimicrob Agents Chemother. 2013. PMID: 23165464 Free PMC article.
-
Prioritization of Susceptibility Genes for Ectopic Pregnancy by Gene Network Analysis.Int J Mol Sci. 2016 Feb 1;17(2):191. doi: 10.3390/ijms17020191. Int J Mol Sci. 2016. PMID: 26840308 Free PMC article.
-
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review.Pharmacol Ther. 2013 Jun;138(3):333-408. doi: 10.1016/j.pharmthera.2013.01.016. Epub 2013 Feb 4. Pharmacol Ther. 2013. PMID: 23384594 Free PMC article. Review.
-
Collateral Sensitivity to β-Lactam Drugs in Drug-Resistant Tuberculosis Is Driven by the Transcriptional Wiring of BlaI Operon Genes.mSphere. 2021 Jun 30;6(3):e0024521. doi: 10.1128/mSphere.00245-21. Epub 2021 May 28. mSphere. 2021. PMID: 34047652 Free PMC article.
-
Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein-protein interaction network.Clin Transl Med. 2015 Dec;4(1):61. doi: 10.1186/s40169-015-0061-6. Epub 2015 Jun 5. Clin Transl Med. 2015. PMID: 26061871 Free PMC article.
References
-
- Simon JW, Richard AS, Ken L, Laurent K, Robert CR, Gurdyal SB. The use of microarray analysis to determine the gene expression profiles of mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis (Edinburgh, Scotland) 2004;84(3):263–274. doi: 10.1016/j.tube.2003.12.005. - DOI - PMC - PubMed
-
- Qiu YQ, Zhang S, Zhang XS. Uncovering differentially expressed pathways with protein interaction and gene expression data. The Second International Symposium on Optimization and Systems Biology. 2008. pp. 74–82.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous